PolyCore Therapeutics – News – PolyCore Therapeutics

The Latest

News from

PolyCore

PolyCore Therapeutics Appoints Christopher M. Cashman to Board of Directors

February 22, 2021

PHILADELPHIA, Pa, February 22, 2021 – PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative… Read More

PolyCore Therapeutics Awarded $1.5 Million NIH Grant to Advance Lead Compound, PCT-3012

August 20, 2020

PHILADELPHIA, Pa, August 20, 2020 — PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative… Read More

PolyCore Therapeutics Announces the Appointment of Kelly Beck as Chief Executive Officer

July 20, 2020

PHILADELPHIA, Pa, July 20, 2020 — PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative… Read More